References
Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ, Schumacher HR (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. In press
Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623–1629
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431–1446
Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447–1461
Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66:1311–1315
Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301–1311
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324
Dalbeth N (2013) Management of gout in primary care: challenges and potential solutions. Rheumatology (Oxford) 52:1549–1550
Acknowledgments
The authors would like to give special acknowledgments to Dr Laure Perrissin for being involved in the project. This work was supported by the Menarini Pharmaceutical Group.
Conflicts of interest
Tristan Pascart has no conflict of interest to declare. René-Marc Flipo is member of the Menarini France scientific board.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pascart, T., Flipo, RM. Gout: from international guidelines to current practice. Results from a physician questionnaire. Clin Rheumatol 32, 1693–1694 (2013). https://doi.org/10.1007/s10067-013-2402-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2402-4